SCHEMBL1683358

SCHEMBL1683358

CC(C)(C)[PH](=O)c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP2C19 P33261 1/20 0.32
HIF1A Q16665 1/20 0.32
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC10 Q969S8 1/20 0.31
HDAC11 Q96DB2 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31
ALDH1A1 P00352 3/20 0.31
TAAR1 Q96RJ0 2/20 0.31
ALOX15 P16050 1/20 0.31
SLC6A2 P23975 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5966339 0.75 ESR1 (0.42) MAPTKMT2AHIF1AALDH1A1ALOX15
SCHEMBL9392778 0.75 KMT2A (0.36) MAPTKMT2ACYP2C19HIF1AHDAC3
SCHEMBL27780328 0.74 ALDH1A1 (0.38) HDAC6ALDH1A1ELANETSHR
SCHEMBL2154648 0.69
SCHEMBL12394342 0.69 TSHR (0.39) ALDH1A1TSHRACHECYP3A4HSD17B10
SCHEMBL8154595 0.69 ALDH1A1 (0.35) MAPK1MAPTKMT2AALDH1A1ALOX15
SCHEMBL4924726 0.69 GAA (0.34) MAPK1MAPTKMT2ACYP2C19HIF1A
SCHEMBL23331409 0.68 MAPK1 (0.33) MAPK1ALDH1A1TAAR1ALOX15SLC6A2
SCHEMBL13583073 0.67 ALDH1A1 (0.35) MAPTALDH1A1ALOX15TSHRLMNA
SCHEMBL1667 0.67 ALDH1A1 (0.35) MAPTALDH1A1ALOX15TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114181250-A Alkenyl phosphine compound and preparation method thereof 中国石油化工股份有限公司 2022-03-15 CN claimed
EP-2639233-B1 Phosphine oxide, a process for the manufacture thereof and application thereof CENTRUM BADAN MOLEKULARNYCH I MAKROMOLEKULARNYCH PAN (PL) 2017-01-04 EP claimed
EP-2639233-A1 Phosphine oxide, a process for the manufacture thereof and application thereof Centrum Badan Molekularnych I Makromolekularnych Pan (PL) 2013-09-18 EP claimed
CN-119176840-A Phosphorus-containing (meth) acryl composition, method for producing same, flame-retardant resin composition, prepreg, and use thereof 日铁化学材料株式会社 2024-12-24 CN disclosed
CN-118440115-A Asymmetric synthesis method of axial chiral biaryl-aryl phosphine oxide 上海交通大学 2024-08-06 CN disclosed
US-12012426-B2 Tetradentate diaminodiphosphine ligand and transition metal complex, and method for manufacturing same and application for same TAKASAGO INTERNATIONAL CORPORATION (JP) 2024-06-18 US disclosed
CN-112654630-B Tetradentate diaminodiphosphine ligands, transition metal complexes, methods for their production and use thereof 高砂香料工业株式会社 2024-05-24 CN disclosed
WO-2023167148-A1 PHOSPHORUS-CONTAINING (METH)ACRYLOYL COMPOUND, PRODUCTION METHOD THEREFOR, FLAME-RETARDANT RESIN COMPOSITION CONTAINING PHOSPHORUS-CONTAINING (METH)ACRYLOYL COMPOUND, CURED PRODUCT, AND LAMINATED BOARD FOR ELECTRONIC CIRCUIT BOARD 日鉄ケミカル&マテリアル株式会社 2023-09-07 WO disclosed
WO-2023167019-A1 PHOSPHORUS-CONTAINING (METH)ACRYLOYL COMPOUND, METHOD FOR PRODUCING SAME, AND FLAME-RETARDANT COMPOSITION AND LAMINATED BOARD FOR ELECTRONIC CIRCUIT BOARD CONTAINING SAME 日鉄ケミカル&マテリアル株式会社 2023-09-07 WO disclosed
CN-116655686-A Synthesis method and application of pentavalent and trivalent tridentate phosphine ligand 广东欧凯新材料有限公司 2023-08-29 CN disclosed
US-20230219983-A1 TETRADENTATE DIAMINODIPHOSPHINE LIGAND AND TRANSITION METAL COMPLEX, AND METHOD FOR MANUFACTURING SAME AND APPLICATION FOR SAME TAKASAGO INTERNATIONAL CORPORATION (JP) 2023-07-13 US disclosed
US-20110098485-A1 BIDENTATE SECONDARY PHOSPHINE OXIDE CHIRAL LIGANDS FOR USE IN ASYMMETRIC ADDITION REACTIONS SOLVIAS AG (CH) 2011-04-28 US disclosed
US-20100317866-A1 IMIDAZOLE GROUP-CONTAINING PHOSPHORUS COMPOUNDS BASF SE (DE) 2010-12-16 US disclosed
US-20100317866-A1 IMIDAZOLE GROUP-CONTAINING PHOSPHORUS COMPOUNDS BASF SE (DE) 2010-12-16 US disclosed
CN-101868468-A Bidentate secondary phosphine oxide chiral ligands for asymmetric addition reactions SOLVIAS AG 2010-10-20 CN disclosed
EP-2212340-A1 BIDENTATE SECONDARY PHOSPHINE OXIDE CHIRAL LIGANDS FOR USE IN ASYMMETRIC ADDITION REACTIONS Solvias AG (CH) 2010-08-04 EP disclosed
US-20100174079-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE PHOSPHOROUS COMPOUND NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE TECHNOLOGY (JP) 2010-07-08 US disclosed
US-20090171114-A1 Chiral Ligands Used in Transition Metal Catysts for Asymmetric Addition Reactions Especially Hydrogenation SOLVIAS AG (CH) 2009-07-02 US disclosed
WO-2009065783-A1 BIDENTATE SECONDARY PHOSPHINE OXIDE CHIRAL LIGANDS FOR USE IN ASYMMETRIC ADDITION REACTIONS SOLVIAS AG (CH) 2009-05-28 WO disclosed
WO-2007135179-A1 CHIRAL LIGANDS USED IN TRANSITION METAL CATALYSTS FOR ASYMMETRIC ADDITION REACTIONS ESPECIALLY HYDROGENATION SOLVIAS AG (CH) 2007-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098485-A1 BIDENTATE SECONDARY PHOSPHINE OXIDE CHIRAL LIGANDS FOR USE IN ASYMMETRIC ADDITION REACTIONS H1-2, PHOSPHO1, H1-0 MAPK1 1062/4885MAPT 4850/4885KMT2A 1813/4885
US-20230219983-A1 TETRADENTATE DIAMINODIPHOSPHINE LIGAND AND TRANSITION METAL COMPLEX, AND METHOD FOR MANUFACTURING SAME AND APPLICATION FOR SAME ADH4, ADH5, PF4 MAPK1 4189/4885MAPT 1502/4885KMT2A 1576/4885
US-12012426-B2 Tetradentate diaminodiphosphine ligand and transition metal complex, and method for manufacturing same and application for same ADH4, ADH5, PF4 MAPK1 4189/4885MAPT 1502/4885KMT2A 1576/4885
US-20090171114-A1 Chiral Ligands Used in Transition Metal Catysts for Asymmetric Addition Reactions Especially Hydrogenation HRH3, HRH4, HRH1 MAPK1 1443/4885MAPT 4624/4885KMT2A 2273/4885
US-20100174079-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE PHOSPHOROUS COMPOUND AGL, RPS4X, MRPL9 MAPK1 1048/4885MAPT 3911/4885KMT2A 3742/4885
US-20100317866-A1 IMIDAZOLE GROUP-CONTAINING PHOSPHORUS COMPOUNDS ITPA, PPIP5K2, IPMK MAPK1 2262/4885MAPT 1288/4885KMT2A 2838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.